These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 3127585)
1. The cost effectiveness of auranofin: results of a randomized clinical trial. Thompson MS; Read JL; Hutchings HC; Paterson M; Harris ED J Rheumatol; 1988 Jan; 15(1):35-42. PubMed ID: 3127585 [TBL] [Abstract][Full Text] [Related]
2. Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis. Champion GD; Cairns DR; Bieri D; Adena MA; Browne CD; Cohen ML; Day RO; Edmonds JP; Graham GG; de Jager J J Rheumatol; 1988 Jan; 15(1):28-34. PubMed ID: 3280795 [TBL] [Abstract][Full Text] [Related]
3. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine. Leonard PA; Bienz SR; Clegg DO; Ward JR J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632 [TBL] [Abstract][Full Text] [Related]
4. Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study. Borg G; Allander E; Lund B; Berg E; Brodin U; Pettersson H; Trang L J Rheumatol; 1988 Dec; 15(12):1747-54. PubMed ID: 14552308 [TBL] [Abstract][Full Text] [Related]
5. [Clinical effectiveness and tolerance of auranofin in patients with chronic polyarthritis. Results of a multicenter long-term study]. Klein G; Schwann H; Mirtl B; Thumb N; Mayerhofer F; Singer F; Tausch G; Gaismayer K; Rieder H; Hartweger A Z Rheumatol; 1988; 47(5):342-6. PubMed ID: 3149087 [TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy and safety of auranofin: a review of clinical experience. Blodgett RC; Pietrusko RG Scand J Rheumatol Suppl; 1986; 63():67-78. PubMed ID: 3110943 [TBL] [Abstract][Full Text] [Related]
7. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate. Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial. Ogrendik M Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134 [TBL] [Abstract][Full Text] [Related]
9. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial. Bombardier C; Ware J; Russell IJ; Larson M; Chalmers A; Read JL Am J Med; 1986 Oct; 81(4):565-78. PubMed ID: 3532786 [TBL] [Abstract][Full Text] [Related]
10. Double-blind randomized trial of diclofenac sodium versus placebo in patients with rheumatoid arthritis. Weisman MH Clin Ther; 1986; 8(4):427-38. PubMed ID: 3524843 [TBL] [Abstract][Full Text] [Related]
11. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study. Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483 [TBL] [Abstract][Full Text] [Related]
12. [A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and their associative factors]. Hashimoto A; Sato H; Nishibayahi Y; Shiino Y; Kutsuna T; Ishihara Y; Hoshi K; Fujimori J; Tsuboi S; Kondo H; Akizuki M; Moroi Y; Yoshida S Ryumachi; 2002 Feb; 42(1):23-39. PubMed ID: 11925904 [TBL] [Abstract][Full Text] [Related]
13. Economic evaluation of oral valdecoxib versus diclofenac in the treatment of patients with rheumatoid arthritis in a randomized clinical trial. von Scheele B; Peña B; Wong J; Niculescu L Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii53-9. PubMed ID: 14585918 [TBL] [Abstract][Full Text] [Related]
14. Postmarketing experience with auranofin in the Federal Republic of Germany. Schattenkirchner M; Missler B; Mulz D Scand J Rheumatol Suppl; 1986; 63():57-66. PubMed ID: 3299683 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of auranofin as demonstrated by improvement in clinical parameters and decrease in anti-inflammatory usage: a long-term, multicenter study. Brenol JC; Chahade W; De Freitas GG; De Pádua PM; Rachid A; Samara A; Seda H; Ximenes AC Scand J Rheumatol Suppl; 1986; 63():37-45. PubMed ID: 3299682 [TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of etanercept (Enbrel) in combination with methotrexate in the treatment of active rheumatoid arthritis based on the TEMPO trial. Kobelt G; Lindgren P; Singh A; Klareskog L Ann Rheum Dis; 2005 Aug; 64(8):1174-9. PubMed ID: 15708879 [TBL] [Abstract][Full Text] [Related]
17. [Comparative effectiveness of chrysanol and auranofin in rheumatoid arthritis]. Atakhodzhaeva ZA; Sigidin IaA Ter Arkh; 1987; 59(12):30-3. PubMed ID: 3328906 [TBL] [Abstract][Full Text] [Related]
18. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group. Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358 [TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis. Katz WA; Alexander S; Bland JH; Blechman W; Bluhm GB; Bonebrake RA; Falbo A; Greenwald RA; Hartman S; Hobbs T; Indenbaum S; Lergier JE; Lanier BG; Lightfoot RW; Phelps P; Sheon RP; Torretti D; Wenger ME; Wilske K J Rheumatol Suppl; 1982; 8():173-8. PubMed ID: 6813481 [TBL] [Abstract][Full Text] [Related]
20. Short-term study of indoprofen in comparison with placebo and indomethacin in rheumatoid arthritis. Delbarre F Eur J Rheumatol Inflamm; 1981; 4(1):66-73. PubMed ID: 7042364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]